GC1109

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC1109, covering 2023-01-04 to 2023-01-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 [Phase 2]